MULTIMODAL ASSESSMENT & NOVEL TREATMENT
FOR THE NEURO-ICU

 
 
 
 

Prof. Ofer Barnea

CEO, Founder

  • Grey LinkedIn Icon

Professor of Biomedical Engineering and former chairman of the Department of BME at TAU. BSc in EE@TAU; PhD in BME at Drexel. 30 years experience in the medical device industry. Founded several companies and led the development of medical devices as a consultant

Or Zigelboim, VP R&D

  • Grey LinkedIn Icon

BSc in Mechanical Engineering at TAU. Product manager with over 8 years in the field of endovascular. Proven experience in developing vascular implants from concept stage to CE mark.

Dr Omer Doron, MD

CMO, Founder

  • Grey LinkedIn Icon

Neurosurgery Department , Neurocritical Care and Endovascular Service, Maimonides University Medical Center, Haifa. PhD candidate, Dept. of BME, TAU. Author of several peer-reviewed papers on cranial dynamics. Past : Airborne Doctor in the IDF.

Dr. Ofer Hornik, MD

Regulatory Mgr.

  • Grey LinkedIn Icon

A physician in training, with 25 years of program management, product management, clinical & regulatory management, entrepreneurial, and executive positions in numerous healthcare startup companies.

Shimon Oz, MA (Econ.) MBA,

CFO

  • Grey LinkedIn Icon

Held senior financial and executive positions; focused on MedTech SUs. Held CFO, CEO, Chief Accountant, and BoD member in e.g.: Urden Industries, Claridge SB, Idanit (now HP), Objet (Sratasys) Jemtex and others. MA Economics, MBA HUJI.

 

Contact: CEO; Prof. Ofer Barnea, Ph.D

© 2018 SynCath | All Rights Reserved | Design by WixMeUp